Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude's Epiducer now global with US clearance; gets go-ahead for BROADENing DBS study

This article was originally published in Clinica

Executive Summary

St Jude Medical has received the green light to market its Epiducer neurostimulation lead delivery system in the US. The 510(k) clearance from the FDA comes over a year after the system was CE marked; it is now currently St Jude's best-selling neurostimulation lead delivery system in Europe, the firm had told Clinica at the annual International Neuromodulation Society meeting in London earlier this year (www.clinica.co.uk, 25 May 2011).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097592

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel